myocardial infarction

K. PETER RENTROP, M.D. THROMBOLYTIC THERAPY in patients with acute myocardial infarction has received renewed attention since intracoronary infusion of streptokinase has been introduced into clinical practice. Efficacy of intracoronary infusion of streptokinase. In-tracoronary infusion of streptokinase results in recana-lization of approximately 75 % of completely obstruct-ed infarct-related vessels " 2 (table 1). Modifications of the technique, such as subselective infusion of strepto-kinase via small catheters, increased infusion rate, or injection of a bolus at the initiation of therapy, have not resulted in reproducibly higher recanalization rates3'-2 (table 1). The-influence of intracoronary infusion of streptokinase on ejection fractiom has been assessed i